薬剤部

Keyphrases

1. 1-deoxynojirimycin 27%
2. Acetamido 12%
3. Acetic Acid 6%
4. Active Sites 7%
5. Aldose Reductase 9%
6. Alkaloids 27%
7. Alkyl 18%
8. Alkyl Chain 9%
9. Allyl 7%
10. Amides 10%
11. Amino Acids 8%
12. Asymmetric Synthesis 12%
13. Azepane 16%
14. Azetidine 13%
15. Benzyl 7%
16. Bicyclol 10%
17. Biological Activity 11%
18. Biological Evaluation 21%
19. Broussonetines 6%
20. Butyl 7%
21. Calystegines 28%
22. Carboxylic Acids 7%
23. Castanospermum Australe 7%
24. CFTR mutations 6%
25. Competitive Inhibitor 12%
26. Convolvulaceae 6%
27. Cyclic Nitrones 15%
28. Docking Studies 7%
29. Enantiomeric 9%
30. Endoplasmic Reticulum 8%
31. Epimer 8%
32. Epimeric 6%
33. Fabry Disease 17%
34. Fagomine 10%
35. Flavonoids 6%
36. Fluorinated 8%
37. Fluorinated Derivatives 6%
38. Fucosidase 10%
39. Gaucher Disease 14%
40. General Synthesis 6%
41. Glucocerebrosidase 15%
42. Glucosidase 54%
43. Glucuronolactone 10%
44. Glycogen Phosphorylase 9%
45. Glycosidase 49%
46. Glycosidase Inhibition 62%
47. Glycosidase Inhibitors 27%
48. Hyacinthacine 14%
49. Hydroxymethyl 10%
50. IC50 17%
51. IC50 Value 20%
52. Imino 39%
53. Iminosugars 100%
54. In Vitro Inhibition 7%
55. Inhibitory Activity 28%
56. Inhibitory Effect 8%
57. Isofagomine 6%
58. Isomaltase 6%
59. Lactones 8%
60. Looking Glass 8%
61. Maltase 11%
62. Mannitol 12%
63. Mannosidase 12%
64. Methyl 16%
65. Miglitol 8%
66. Mouse Model 6%
67. Naringinase 6%
68. Natural Products 11%
69. Nitrones 7%
70. Nojirimycin 6%
71. Overall Yield 8%
72. Oxaliplatin 6%
73. Pharmacological Chaperone 22%
74. Piperidine 6%
75. Polyhydroxylated 24%
76. Potent Inhibitor 34%
77. Proline 8%
78. Pyrrolidine 27%
79. Pyrrolidine Alkaloids 7%
80. Pyrrolizidine 11%
81. Pyrrolizidine Alkaloids 7%
82. Ring-closing Metathesis 7%
83. SAR Study 8%
84. Selective Inhibitor 9%
85. Side Chain 11%
86. Stereoisomers 19%
87. Stereoselectivity 6%
88. Steviamine 6%
89. Structure-activity Relationship 8%
90. Sucrase 10%
91. Swainsonine 9%
92. Synthetic Evaluation 16%
93. Total Synthesis 16%
94. Trehalase 7%
95. α-glucosidase Inhibition 8%
96. α-glucosidase Inhibitor 24%
97. α-L-rhamnosidase 8%
98. β-Galactosidase (β-Gal) 36%
99. β-hexosaminidase 8%
100. β-N-acetylhexosaminidase 9%

Pharmacology, Toxicology and Pharmaceutical Science

1. 1 Deoxymannonojirimycin 6%
2. 1-Deoxynojirimycin 24%
3. 2,5-Dimethoxy-4-iodoamphetamine 5%
4. Acetic Acid Derivative 6%
5. Acetylglucosaminidase 7%
6. Aldehyde Reductase 6%
7. Allyl 5%
8. Alpha Glucosidase 15%
9. Alpha Levo Fucosidase 12%
10. Amino Acid 10%
11. Aminoalcohol 5%
12. Arabinitol 10%
13. Azetidine 11%
14. Beta Glucuronidase 7%
15. Beta N Acetylhexosaminidase 9%
16. Biological Activity 11%
17. Carbon 13 5%
18. Carboxamide 10%
19. Carboxylate 6%
20. Castanospermum 6%
21. Competitive Inhibitor 11%
22. Convolvulaceae 5%
23. Fabry Disease 13%
24. Fagomine 6%
25. Functional Groups 5%
26. Galactose 10%
27. Galactosidase 37%
28. Gaucher's Disease 11%
29. Glucosidase 82%
30. Glucosylceramidase 18%
31. Glycogen Phosphorylase 12%
32. Glycosidase 56%
33. Glycosidase Inhibitor 15%
34. Glycoside 10%
35. Hyacinthaceae 5%
36. Hyperglycemia 7%
37. IC50 39%
38. Iminosugar 79%
39. Indolizidine Alkaloid 5%
40. Lysosome Storage Disease 6%
41. Mannitol 13%
42. Mannosidase 7%
43. Migalastat 5%
44. Miglitol 8%
45. Morus 6%
46. Mouse Model 5%
47. Natural Product 20%
48. Nitrone 16%
49. Non Insulin Dependent Diabetes Mellitus 5%
50. Oligo 1,6 Glucosidase 5%
51. Oxaliplatin 6%
52. Pharmacological Chaperone 21%
53. Piperidine 5%
54. Proline 6%
55. Pyrrolidine Derivative 35%
56. Pyrrolizidine 11%
57. Pyrrolizidine Alkaloid 6%
58. Scilla 6%
59. Sorbitol 8%
60. Structure Activity Relationship 16%
61. Sucrase 9%
62. Swainsonine 8%
63. Trehalase 9%